tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Aligos Therapeutics assumed with a Buy at H.C. Wainwright

H.C. Wainwright assumed coverage of Aligos Therapeutics (ALGS) with a Buy rating and $50 price target The firm has conviction that ALG-000184 can become the new standard-of-care for chronic suppression of hepatitis B virus, while also serving as the oral backbone to future functional cure regimens.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1